OS Acquisition Corp.
Status: Stalled
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $150.00M |
|---|---|
| IPO Date | * |
| CEO | Jeff Klunzinger |
| Left Lead | Citigroup |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Technology-enabled drug discovery, food and agriculture technology, genomics and diagnostics, life science tools, and sustainability |
| IPO Geography | Global |
| Target Company | TBD |
| Deal Announced | TBD |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
OSAA
OSAAU
OSAAW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on OS Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 2 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jeff Klunzinger | 43 | Director and Chief Executive Officer |
| Mark Ghobrial | 35 | Chief Financial Officer |
| Lily Kim | 45 | Director and Chief Scientific Officer |
| Doug Cameron | 63 | Director |
| Luba Greenwood | 42 | Director |
| William Noglows | 63 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Citigroup | BR | 15,000,000 | units |
| 15,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 2 filings.